164 related articles for article (PubMed ID: 16908426)
1. Towards a universal dissolution medium for carbamazepine.
El-Massik MA; Abdallah OY; Galal S; Daabis NA
Drug Dev Ind Pharm; 2006 Aug; 32(7):893-905. PubMed ID: 16908426
[TBL] [Abstract][Full Text] [Related]
2. Surfactant-facilitated crystallization of dihydrate carbamazepine during dissolution of anhydrous polymorph.
Rodríguez-Hornedo N; Murphy D
J Pharm Sci; 2004 Feb; 93(2):449-60. PubMed ID: 14705201
[TBL] [Abstract][Full Text] [Related]
3. Effects of coformers on phase transformation and release profiles of carbamazepine cocrystals in hydroxypropyl methylcellulose based matrix tablets.
Qiu S; Li M
Int J Pharm; 2015 Feb; 479(1):118-28. PubMed ID: 25542989
[TBL] [Abstract][Full Text] [Related]
4. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
5. Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder.
Murphy D; Rodríguez-Cintrón F; Langevin B; Kelly RC; Rodríguez-Hornedo N
Int J Pharm; 2002 Oct; 246(1-2):121-34. PubMed ID: 12270615
[TBL] [Abstract][Full Text] [Related]
6. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.
Sethia S; Squillante E
Int J Pharm; 2004 Mar; 272(1-2):1-10. PubMed ID: 15019063
[TBL] [Abstract][Full Text] [Related]
7. In vitro/in vivo correlations of dissolution data of carbamazepine immediate release tablets with pharmacokinetic data obtained in healthy volunteers.
Lake OA; Olling M; Barends DM
Eur J Pharm Biopharm; 1999 Jul; 48(1):13-9. PubMed ID: 10477323
[TBL] [Abstract][Full Text] [Related]
8. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
[TBL] [Abstract][Full Text] [Related]
9. Investigation of intrinsic dissolution behavior of different carbamazepine samples.
Sehić S; Betz G; Hadzidedić S; El-Arini SK; Leuenberger H
Int J Pharm; 2010 Feb; 386(1-2):77-90. PubMed ID: 19900519
[TBL] [Abstract][Full Text] [Related]
10. Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer.
Yamashita H; Sun CC
Pharm Res; 2017 Dec; 35(1):4. PubMed ID: 29288433
[TBL] [Abstract][Full Text] [Related]
11. Evaluation and selection of bio-relevant dissolution media for a poorly water-soluble new chemical entity.
Tang L; Khan SU; Muhammad NA
Pharm Dev Technol; 2001 Nov; 6(4):531-40. PubMed ID: 11775954
[TBL] [Abstract][Full Text] [Related]
12. Influence of Simulated Gastrointestinal Fluids on Polymorphic Behavior of Anhydrous Carbamazepine Form III and Biopharmaceutical Relevance.
Bhise SB; Rajkumar M
PDA J Pharm Sci Technol; 2010; 64(1):28-36. PubMed ID: 21502001
[TBL] [Abstract][Full Text] [Related]
13. Expedited Tablet Formulation Development of a Highly Soluble Carbamazepine Cocrystal Enabled by Precipitation Inhibition in Diffusion Layer.
Yamashita H; Sun CC
Pharm Res; 2019 Apr; 36(6):90. PubMed ID: 31016440
[TBL] [Abstract][Full Text] [Related]
14. Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release.
Marchais H; Cayzeele G; Legendre JY; Skiba M; Arnaud P
Eur J Pharm Sci; 2003 Jun; 19(2-3):129-32. PubMed ID: 12791415
[TBL] [Abstract][Full Text] [Related]
15. Dissolution media for in vitro testing of water-insoluble drugs: effect of surfactant purity and electrolyte on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate.
Crison JR; Weiner ND; Amidon GL
J Pharm Sci; 1997 Mar; 86(3):384-8. PubMed ID: 9050810
[TBL] [Abstract][Full Text] [Related]
16. Material-Sparing and Expedited Development of a Tablet Formulation of Carbamazepine Glutaric Acid Cocrystal- a QbD Approach.
Yamashita H; Sun CC
Pharm Res; 2020 Jul; 37(8):153. PubMed ID: 32705421
[TBL] [Abstract][Full Text] [Related]
17. Understanding impact of pre-dissolved polymers on dissolution behavior of soluble carbamazepine cocrystal.
Ullah M; Khan SA; Shah SM; Rabbani I; Sadozai SK; Abbas N; Bin Asad MHH; Badshah M; Hasan SMF; Hussain I
Pak J Pharm Sci; 2019 May; 32(3):1049-1055. PubMed ID: 31278719
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the effect of hydroxypropyl methylcellulose on the phase transformation and release profiles of carbamazepine-nicotinamide cocrystal.
Li M; Qiu S; Lu Y; Wang K; Lai X; Rehan M
Pharm Res; 2014 Sep; 31(9):2312-25. PubMed ID: 24590881
[TBL] [Abstract][Full Text] [Related]
19. Chemometric Models for Quantification of Carbamazepine Anhydrous and Dihydrate Forms in the Formulation.
Barakh Ali SF; Rahman Z; Dharani S; Afrooz H; Khan MA
J Pharm Sci; 2019 Mar; 108(3):1211-1219. PubMed ID: 30773201
[TBL] [Abstract][Full Text] [Related]
20. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.
Qiao N; Wang K; Schlindwein W; Davies A; Li M
Eur J Pharm Biopharm; 2013 Apr; 83(3):415-26. PubMed ID: 23159709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
